Ensurge Micropower ASA Successfully Issues 111.1 Million Shares and Launches Subsequent Offering
Written by Emily J. Thompson, Senior Investment Analyst
Source: Globenewswire
Updated: 52 minutes ago0mins
- Successful Placement: Ensurge Micropower ASA completed a private placement of 111,111,111 new shares on November 9, 2025, strengthening its capital base to support future growth initiatives.
- Subsequent Offering Plan: The Extraordinary General Meeting on December 3, 2025, approved a subsequent offering to issue up to 22,222,222 new shares, further expanding financing avenues to meet market demand.
- Subscription Rights Allocation: Each eligible shareholder will receive 0.042889 subscription rights per share held, ensuring existing shareholders have preferential rights in the offering, thereby protecting shareholder interests.
- Trading Arrangements: The subscription period for the offering starts on December 5, 2025, and ends on December 12, with expected delivery of new shares on December 22, ensuring timely capital influx to support the company's operations and growth.
ENSG.O
$0.0000%Past 6 months
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
No Data
Powered By
Intellectia
Analyst Views on ENSG
Wall Street analysts forecast ENSG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENSG is 199.00 USD with a low forecast of 170.00 USD and a high forecast of 220.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 178.990
Low
170.00
Averages
199.00
High
220.00
Current: 178.990
Low
170.00
Averages
199.00
High
220.00
RBC Capital
Outperform
maintain
$177 -> $206
2025-11-14
Reason
RBC Capital
Price Target
$177 -> $206
2025-11-14
maintain
Outperform
Reason
RBC Capital raised the firm's price target on Ensign Group to $206 from $177 and keeps an Outperform rating on the shares after its Q3 earnings beat. The firm was pleased to see Ensign deliver strong performance, with the company posting a beat and raise with adjusted EBITDAR 3.0% above consensus as it exhibited consistent operational momentum supported by improvements in same-store and transitioning facility metrics, the analyst tells investors in a research note.
Truist
Hold
maintain
$190 -> $200
2025-11-10
Reason
Truist
Price Target
$190 -> $200
2025-11-10
maintain
Hold
Reason
Truist raised the firm's price target on Ensign Group to $200 from $190 and keeps a Hold rating on the shares. The firm is updating its model to reflect the company's Q3 earnings beat and guidance raise, the analyst tells investors in a research note. Truist adds it is positive on Ensign's local structure, unique M&A strategy and solid relative positioning, though it also notes that the labor market disruption and regulatory pressures have created sector challenges.
UBS
Buy
maintain
$205 -> $220
2025-11-05
Reason
UBS
Price Target
$205 -> $220
2025-11-05
maintain
Buy
Reason
UBS raised the firm's price target on Ensign Group to $220 from $205 and keeps a Buy rating on the shares. The firm sees "plenty" of tailwinds looking to the future, the analyst tells investors in a research note.
Truist
David MacDonald
Hold
maintain
$165 -> $190
2025-10-14
Reason
Truist
David MacDonald
Price Target
$165 -> $190
2025-10-14
maintain
Hold
Reason
Truist analyst David MacDonald raised the firm's price target on Ensign Group to $190 from $165 and keeps a Hold rating on the shares as part of a broader research note previewing Q3 results in Healthcare Service. The firm is "broadly bullish" on the industry as it expects ongoing strength in core demand drivers and continues to like the long-term positioning of covered names within their sector verticals, coupled with improved visibility around the regulatory environment, the analyst tells investors in a research note. Strong free cash flows and attractive financial flexibility across the bulk of the sector underpins the ongoing growth investment, Truist notes, adding that it sees a "brisk opportunity" to deploy capital to further augment core growth and drive M&A.
See All Ratings
About ENSG
The Ensign Group, Inc., through its independent operating subsidiaries, offers a range of skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate. The Company's segments include Skilled Services and Standard Bearer. The Skilled Services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment is comprised of select properties owned by it through its captive real estate investment trust (REIT) and leased to skilled nursing and senior living operations, including its own independent subsidiaries and third-party operators. The Company has over 373 healthcare operations, which includes 47 senior living operations, across 17 states. Its subsidiaries, including Standard Bearer Healthcare REIT, Inc., own around 156 real estate assets. Its operations are located in Alabama, Alaska, Arizona, California, Colorado and other locations.
About the author
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sigh Up to Get Intellectia Insights
What is momentum investing and how does it work?
How does the Zacks Momentum Style Score evaluate stock performance?
Will Ensign Group's stock continue to outperform the S&P 500?
Can the upward revision of earnings estimates sustain Ensign Group's growth?